Jie Te Chen

Address:

19271 Northfleet Way, Tarzana, CA 91356

VIN:

WDDNG76X47A094800

Make:

MERCEDES-BENZ

Model:

S-CLASS

Year:

2007

US Patent:

7288538, Oct 30, 2007

Filed:

Aug 23, 2004

Appl. No.:

10/924180

Inventors:

Chengde Wu - Pearland TX, US
Daxin Gao - Houston TX, US
Ronald Biediger - Houston TX, US
Jie Chen - Houston TX, US
Robert V. Market - Pearland TX, US

Assignee:

Encysive Pharmaceuticals, Inc. - Houston TX

International Classification:

A61K 31/5375
A61K 31/4523
A61K 31/4025
A61K 31/381
C07D 413/10
C07D 409/10

US Classification:

51421019, 5142315, 514326, 514422, 514444, 544146, 546213, 548527, 548950, 549 59, 549 60

Abstract:

The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.

US Patent:

7579340, Aug 25, 2009

Filed:

Aug 22, 2007

Appl. No.:

11/895069

Inventors:

Ronald Biediger - Houston TX, US
Jie Chen - Houston TX, US
Daxin Gao - Houston TX, US
Robert Market - Pearlman TX, US
Chengde Wu - Pearland TX, US

Assignee:

Pfizer Inc - New York NY

International Classification:

A61K 31/5375
A61K 31/4523
A61K 31/4025
A61K 31/381
C07D 413/10
C07D 409/10

US Classification:

51421019, 5142315, 514326, 514422, 514444, 544146, 546213, 548527, 548950, 549 59, 549 60

Abstract:

The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.

US Patent:

20080188528, Aug 7, 2008

Filed:

Dec 21, 2007

Appl. No.:

12/004956

Inventors:

Ronald J. Biediger - Houston TX, US
Huong M. Bui - Pearland TX, US
Jie Chen - Houston TX, US
Kevin M. Henry - Pearland TX, US
Thomas Thrash - Houston TX, US

International Classification:

A61K 31/4439
C07D 213/02
A61K 31/44
A61K 31/381
A61K 31/34
A61P 25/00
A61P 31/00
A61P 15/08
A61P 9/00
C07D 307/34
C07D 333/02
A61K 31/19

US Classification:

514341, 546298, 514350, 514557, 562400, 5462747, 549 29, 514438, 549487, 514461

Abstract:

Provided are compounds that are modulators of C3a receptor activity, compositions containing the compounds and methods of use of the compounds and compositions. In certain embodiments, the compounds are pyridones. In certain embodiments, provided are methods for treatment or amelioration of diseases associated with modulation of C3a receptor activity.

US Patent:

20190251484, Aug 15, 2019

Filed:

Feb 11, 2019

Appl. No.:

16/272759

Inventors:

- Indianapolis IN, US
Amin Amini - Irvine CA, US
Jie Chen - Carmel IN, US

International Classification:

G06Q 10/04
G06F 1/3203
G06F 9/30
H02J 3/14

Abstract:

Systems and methods are provided for forecasting and managing daily electrical demands. In some embodiments, a computing platform may receive historical demand data corresponding to historical electrical demand over a first period of time. Next, the computing platform may determine a reference rate of change (ROC) and a statistical mode corresponding to a number of positive ROCs. After, the computing platform may receive current demand data corresponding to current electrical demand over a second period of time. Subsequently, the computing platform may determine an alarm condition corresponding to a daily peak electrical demand. Following, the computing platform may generate one or more commands directing a second computing platform to display the alarm condition. Afterwards, the computing platform may transmit the one or more commands directing the second computing platform to display the alarm condition.